Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160,377,960
-
Total 13F shares
-
109,184,056
-
Share change
-
+18,933,268
-
Total reported value
-
$733,712,379
-
Put/Call ratio
-
52%
-
Price per share
-
$6.72
-
Number of holders
-
143
-
Value change
-
+$131,164,180
-
Number of buys
-
95
-
Number of sells
-
62
Institutional Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q1 2024
As of 31 Mar 2024 Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) had 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 109,184,056 shares of stock of the company.
Largest 10 holders included Kynam Capital Management, LP, STATE STREET CORP, FMR LLC, BlackRock Inc., Point72 Asset Management, L.P., COMMODORE CAPITAL LP, TCG Crossover Management, LLC, VANGUARD GROUP INC, VR Adviser, LLC, and Fairmount Funds Management LLC.
This table shows 142 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.